Keele Research Repository
Explore the Repository
Shoaib, A ORCID: https://orcid.org/0000-0003-0513-8319, Rashid, M
ORCID: https://orcid.org/0000-0001-9725-1583, Kontopantelis, E, Sharp, A, Fahy, EF, Nolan, J, Townend, J, Ludman, P, Ratib, K, Azam, ZA, Ahmad, A, McEntegart, M, Mohamed, MO
ORCID: https://orcid.org/0000-0002-9678-5222, Kinnaird, T, Mamas, MA
ORCID: https://orcid.org/0000-0001-9241-8890, (BCIS), British Cardiovascular Intervention Society and (NICOR), National Institute for Cardiovascular Outcomes Research
(2020)
Clinical Characteristics and Outcomes From Percutaneous Coronary Intervention of Last Remaining Coronary Artery: An Analysis From the British Cardiovascular Intervention Society Database.
Circulation: Cardiovascular Interventions, 13 (9).
e009049 - ?.
![]() |
Text
LRPV Manuscript Ref .docx - Accepted Version Available under License Creative Commons Attribution Non-commercial. Download (15MB) |
Abstract
BACKGROUND: Patients with complex high-risk coronary anatomy, such as those with a last remaining patent vessel (LRPV), are increasingly revascularized with percutaneous coronary intervention (PCI) in contemporary practice. There are limited data on the outcomes of these high-risk procedures. METHODS: We analyzed a large longitudinal PCI cohort (2007-2014, n=501 841) from the British Cardiovascular Intervention Society database. Clinical, demographic, procedural, and outcome data were analyzed by dividing patients into 2 groups; LRPV group (n=2432) and all other PCI groups (n=506 691). RESULTS: Patients in the LRPV PCI group were older, had more comorbidities, and higher prevalence of moderate-severe left ventricular systolic dysfunction. Mortality was higher in the LRPV PCI group during hospital admission (12 % versus 1.5 %, P<0.001), at 30 days (15% versus 2%, P<0.001), and at one-year (24% versus 5%, P<0.001). In a propensity score matching analysis the adjusted risk of mortality during index admission (odds ratio, 2.05 [95% CI, 1.65-2.44], P<0.001), at 30 days (odds ratio, 2.13 [95% CI, 1.78-2.5], P<0.001), at 1 year (odds ratio, 1.81 [95% CI, 1.59-2.03], P<0.001), and in-hospital major adverse cardiovascular events (odds ratio, 1.8 [95% CI, 1.42-2.19], P<0.001) were higher in LRPV PCI group as compared to control group. In sensitivity analyses, similar clinical outcomes were observed irrespective of which major epicardial coronary artery was treated. CONCLUSIONS: In this contemporary cohort, patients who had PCI to their LRPV had a higher-risk profile and more adverse clinical outcomes, irrespective of the vessel treated.
Item Type: | Article |
---|---|
Additional Information: | The final accepted version of this manuscript can be found online with all relevant copyrights information at; https://publications.keele.ac.uk/viewobject.html?id=167961&cid=1 |
Uncontrolled Keywords: | percutaneous coronary intervention; mortality; myocardial infarction; prevalence |
Subjects: | R Medicine > R Medicine (General) R Medicine > RA Public aspects of medicine R Medicine > RC Internal medicine > RC666 Diseases of the circulatory (Cardiovascular) system |
Divisions: | Faculty of Medicine and Health Sciences > School of Primary, Community and Social Care |
Related URLs: | |
Depositing User: | Symplectic |
Date Deposited: | 26 Nov 2020 11:49 |
Last Modified: | 02 Mar 2021 01:30 |
URI: | https://eprints.keele.ac.uk/id/eprint/8935 |
Actions (login required)
![]() |
View Item |